Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,709 | -20,808 | -92,945 | -71,760 | -52,468 |
| Depreciation Amortization | 41 | 21 | 85 | 45 | 29 |
| Accounts payable and accrued liabilities | 826 | -350 | 176 | -261 | 483 |
| Other Working Capital | -10 | -2,112 | -9,279 | -4,147 | -3,130 |
| Other Operating Activity | 5,408 | 2,568 | 18,730 | 16,571 | 13,133 |
| Operating Cash Flow | $-36,444 | $-20,681 | $-83,233 | $-59,552 | $-41,953 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -12 | -67 | -48 | -28 |
| Investing Cash Flow | $-40 | $-12 | $-67 | $-48 | $-28 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 39,589 | 29,643 | 42,841 | 42,020 | N/A |
| Other Financing Activity | 130 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $39,719 | $29,643 | $42,841 | $42,020 | $N/A |
| Exchange Rate Effect | -2,020 | -103 | -130 | 572 | 1,704 |
| Beginning Cash Position | 86,863 | 86,863 | 127,452 | 127,452 | 127,452 |
| End Cash Position | 88,078 | 95,710 | 86,863 | 110,444 | 87,175 |
| Net Cash Flow | $1,215 | $8,847 | $-40,589 | $-17,008 | $-40,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,444 | -20,681 | -83,233 | -59,552 | -41,953 |
| Capital Expenditure | -40 | -12 | -67 | -48 | -28 |
| Free Cash Flow | -36,484 | -20,693 | -83,300 | -59,600 | -41,981 |